A comparison of the effect of methyl-β-cyclodextrin on the osmotic fragility of ovine, bovine and human erythrocytes

Turkish Journal of Veterinary and Animal Sciences

Volumn 27, Issue 2, 2003, Pages 383-387

  Arikan, Şevket ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Bovine; Cyclodextrin; Erythrocyte; Human; Osmotic fragility; Ovine

Indexed keywords

METHYL BETA CYCLODEXTRIN; SODIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CATTLE; CELL SUSPENSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE FRAGILITY; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; NONHUMAN; SHEEP; SPECIES DIFFERENCE;

ANIMALIA; BOS TAURUS; BOVINAE; OVIS; OVIS ARIES;

EID: 0037797438     PISSN: 13000128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pitha, J.: Enhanced water solubility of vitamins A, D, E, and K by substituted cycloamyloses. Life Sci. 1981; 29: 307-311.
2. Pagington, J.S.: β-cyclodextrins: the success of molecular inclusion. Chemistry in Britain. 1987; 23: 455-458
3. Pszczola, D.E.: Production and potential food applications of cyclodextrins. Food Technol.-Chicago 1988; 42: 96-100.
4. Albers, E., Muller, B.W.: Complexation of steroid hormones with cyclodextrin derivatives: substituent effects of the guest molecule on solubility and stability in aqueous solution. J. Pharm. Sci. 1992; 81: 756-761.
5. Irie, T., Fukunaga, K., Pitha, J.: Hydroxypropylcyclodextrins in parenteral use. 1: Lipid dissolution and effects on lipid transverse in vitro. J. Pharm. Sci. 1992; 81: 521-523.
6. Uekama, K., Irie, T.: Cyclodextrins and their industrial uses. In Pharmaceutical applications of methylated cyclodextrin derivatives. Edited by Duchene, D. Editions de Sante, Paris, 1987; 395-439.
7. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilisation. J. Pharm. Sci. 1996; 85: 1017-1025.
8. Kritharides, L.M., Kus, A.J., Brown, W.J., Dean, J.T.: Hydroxypropyl-β-cyclodextrins-mediated efflux of 7-ketocholesterol from macrophage foam cells. J. Biol. Chem. 1996; 271: 27,450-27,455.
9. Haynes, M.P., Phillips, M.C., Pool, G.H.: Efflux of cholesterol from different cellular pools. Biochemistry. 2000; 39: 4508-4517.
10. Ohtani, Y., Irie, T., Uekama, K., Fukunaga, K., Pitha, J.: Differential effects of α-β- and γ-cyclodextrins on human erythrocytes. Eur. J. Biochem. 1989; 186: 17-22.
11. Kilsdonk, E.P.C., Yancey, P.G., Stoudt, G.W., Bangerter, F.W., Johnson, W.J., Phillips, M.C., Rothblat, G.H.: Cellular cholesterol efflux mediated by cyclodextrin. J. Biol. Chem. 1995; 270: 17,250-17,256.
12. Christian, A.E., Haynes, M.P. Phillips, M.C., Rothblat, G.H.: Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 1997; 38: 2264-2272
13. Yancey, P.G., Rodrigueza, W.V., Kilsdonk, E.P.C., Stoudt, G.W., Johnson, W.J., Phillips, M.C., Rothblat, G.H.: Cellular cholesterol efflux mediated by cyclodextrins: demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 1996; 271: 16,026-16,034.
14. Neufeld, E.B., Cooney, A.M., Pitha, J., Dawidowicz, E.A., Dwyer N.K., Pentchev, P.G., Mackie, E.J.B.: Intracellular trafficking of cholesterol monitored with a cyclodextrin. J. Biochem. Chem. 1996; 271: 21604-21613.
15. nd edition. John Wiley and Sons, Inc. New York. USA. 1995; p. 290.
16. Irie, T., Otagiri, M., Sunada, M., Uekama, K., Ohtani, Y., Yamada, Y., Sugiyama, Y.: Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. J. Pharmacobiodyn. 1982; 5: 741-744.
17. Shiotani, K., Uehata, K., Irie, T., Uekama, K., Thomson, D.O., Stella, V.J.: Differential effects of sulphate and sulfobutyl ether of β-cyclodextrins on erythrocyte membranes in vitro. Pharm. Res. 1995; 12: 78-84
18. Perk, K., Frei, Y.F., Herz, A.: Osmotic fragility of red blood cells of young and mature domestic and laboratory animals. Am. J. Vet. Res. 1964; 25: 1241-1248.
19. Soliman, M.K., Amrousi, S.E.: Erythrocyte fragility of healthy fowl, dog, sheep, cattle, buffolo, horse, and camel blood. Vet. Rec. 1966; 78: 429-430.
20. Jikuya, T., Tsutsui, T., Shigeta, O., Sankai, Y., Mitsui, T.: Species differences in erythrocytemechanical fragility: comparison of human, bovine and ovine cells. ASAIO. J. 1998; 44: M452-455.
21. rd edition. Lea and Febiger, Philadelphia. 1975; 122-151.
22. th edition. W.B. Saunders Company, London. 1986; 43-50.
23. Parpart, A.K., Lorenz, P.B., Parpart, E.R., Gregg, J.R., Chase, A.M.: The osmotic resistance (fragility) of human red cells. J. Clin. Invest. 1947; 26: 636-643.
24. Jodal, I., Nanasi, P., Szejtli, J.: Investigation of the haemolytic effect of the cyclodextrin derives. In Advances in inclusion science, Proceedings of the Fourth International Symposium on Cyclodextrins, Munich, West Germany. Edited by Huber, O., Szejtli, J. Kluwer Academic Publishers, Boston. April 20-22, 1988; 421-425.
25. Macarak, E.J., Kumor, K., Weisz, P.B.: Sulfation and haemolytic activity of cyclodextrin. Biochem. Pharm. 1991; 42: 1502-1503.
26. Greatorex, J.C.: Observation on the haematology of calves and various breeds of adult dairy cattle. Brit. Vet. J. 1957; 113: 469-479.
27. Atger, V.M., Moya, M.L., Stoudt, G.W., Rodrigueza, W.V., Phillips, M.C., Rothblat, G.H.: Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J. Clin. Invest. 1997; 99: 773-780.